JP2024512722A5 - - Google Patents
Info
- Publication number
- JP2024512722A5 JP2024512722A5 JP2023560549A JP2023560549A JP2024512722A5 JP 2024512722 A5 JP2024512722 A5 JP 2024512722A5 JP 2023560549 A JP2023560549 A JP 2023560549A JP 2023560549 A JP2023560549 A JP 2023560549A JP 2024512722 A5 JP2024512722 A5 JP 2024512722A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- amino acids
- amino acid
- immunogenic fusion
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21165674.9 | 2021-03-29 | ||
| EP21165674.9A EP4066854A1 (en) | 2021-03-29 | 2021-03-29 | Immunogenic fusion protein |
| PCT/EP2022/058309 WO2022207657A1 (en) | 2021-03-29 | 2022-03-29 | Immunogenic fusion protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512722A JP2024512722A (ja) | 2024-03-19 |
| JP2024512722A5 true JP2024512722A5 (enExample) | 2024-12-23 |
Family
ID=75277909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560549A Pending JP2024512722A (ja) | 2021-03-29 | 2022-03-29 | 免疫原性融合タンパク質 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240173394A1 (enExample) |
| EP (2) | EP4066854A1 (enExample) |
| JP (1) | JP2024512722A (enExample) |
| KR (1) | KR20230163500A (enExample) |
| CN (1) | CN117120081A (enExample) |
| AU (1) | AU2022248869A1 (enExample) |
| BR (1) | BR112023019757A2 (enExample) |
| CA (1) | CA3212987A1 (enExample) |
| IL (1) | IL307256A (enExample) |
| MX (1) | MX2023011502A (enExample) |
| WO (1) | WO2022207657A1 (enExample) |
| ZA (1) | ZA202309225B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4553166A1 (en) | 2023-11-07 | 2025-05-14 | MinervaX ApS | Method for preparing a sample for analysis |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107458A0 (en) | 1992-11-02 | 1994-02-27 | Gen Hospital Corp | Conjugate vaccine against group b streptococcus |
| PT656014E (pt) | 1993-03-19 | 2003-09-30 | Gunnar Lindahl | Proteina rib, uma proteina da superficie celular que confere imunidade a muitas estirpes de estreptococos do grupo b: processo para purificacao da proteina, estojo de reagentes e composicao farmaceutica |
| US6426074B1 (en) | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
| PT2144924T (pt) * | 2007-04-16 | 2016-08-17 | Minervax Aps | Vacina de proteína de fusão |
| EP3365003A1 (en) * | 2015-10-21 | 2018-08-29 | Minervax APS | Immunogenic fusion protein |
| WO2017114655A1 (en) * | 2015-12-30 | 2017-07-06 | Minervax Aps | Immunogenic complex for eliciting protective immunity against group b streptococcus |
-
2021
- 2021-03-29 EP EP21165674.9A patent/EP4066854A1/en not_active Withdrawn
-
2022
- 2022-03-29 CA CA3212987A patent/CA3212987A1/en active Pending
- 2022-03-29 CN CN202280027427.3A patent/CN117120081A/zh active Pending
- 2022-03-29 JP JP2023560549A patent/JP2024512722A/ja active Pending
- 2022-03-29 US US18/284,513 patent/US20240173394A1/en active Pending
- 2022-03-29 EP EP22713429.3A patent/EP4313134A1/en active Pending
- 2022-03-29 IL IL307256A patent/IL307256A/en unknown
- 2022-03-29 BR BR112023019757A patent/BR112023019757A2/pt unknown
- 2022-03-29 AU AU2022248869A patent/AU2022248869A1/en active Pending
- 2022-03-29 KR KR1020237037124A patent/KR20230163500A/ko active Pending
- 2022-03-29 MX MX2023011502A patent/MX2023011502A/es unknown
- 2022-03-29 WO PCT/EP2022/058309 patent/WO2022207657A1/en not_active Ceased
-
2023
- 2023-10-02 ZA ZA2023/09225A patent/ZA202309225B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023521837A5 (enExample) | ||
| JP2022119861A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| JP2023506765A5 (enExample) | ||
| JP2025184979A5 (enExample) | ||
| EP2931896B1 (en) | Modified coiled coil type proteins having improved properties | |
| JP2006149406A5 (enExample) | ||
| RU2009123028A (ru) | F-белок респираторно-синцитиального вируса (rsv) и его применение | |
| JP2019506175A5 (enExample) | ||
| JP2002542827A5 (enExample) | ||
| JP2012515557A5 (enExample) | ||
| JP2012516140A5 (enExample) | ||
| JP2025094154A5 (enExample) | ||
| JP2010532656A5 (enExample) | ||
| HRP20130022T1 (hr) | Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora | |
| WO2026045325A1 (en) | A fusion protein for the prevention of streptococcus pneumoniae infection and its application | |
| JP2021516991A5 (enExample) | ||
| JP2023522154A5 (enExample) | ||
| JP2020502075A (ja) | 肺炎球菌表面プロテインａの選択されたアルファヘリカルドメインおよびプロリンリッチドメインを組み合わせた肺炎球菌ワクチン | |
| CN102178950B (zh) | 一种亚单位疫苗免疫佐剂及应用 | |
| JP2005512518A5 (enExample) | ||
| HUT54733A (en) | Process for producing new, antigenically active proteins and peptides, as well as feline infectious peritonitis virus (fipv) vaccines | |
| JP2011521648A5 (enExample) | ||
| CN106554421B (zh) | 一种抑制链球菌和/或预防链球菌感染的融合蛋白疫苗 |